Overview

A Study Designed to Evaluate Tear Production

Status:
COMPLETED

Trial end date:
2025-01-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate tear production following acute administration of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) in subjects with dry eye disease (DED).

Phase:

PHASE3

Details

Lead Sponsor:

Alcon Research